COGNIGNI, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 361
EU - Europa 118
AS - Asia 54
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 542
Nazione #
US - Stati Uniti d'America 361
IT - Italia 60
CN - Cina 33
IE - Irlanda 25
SG - Singapore 18
SE - Svezia 11
CI - Costa d'Avorio 6
AT - Austria 5
GB - Regno Unito 4
BE - Belgio 3
DE - Germania 3
FI - Finlandia 3
IN - India 3
AU - Australia 1
EU - Europa 1
FR - Francia 1
NL - Olanda 1
RU - Federazione Russa 1
UA - Ucraina 1
VE - Venezuela 1
Totale 542
Città #
Chandler 46
Des Moines 37
Fairfield 34
Ashburn 26
Dublin 21
Ancona 20
Wilmington 19
Boardman 18
Cambridge 17
New York 16
Seattle 16
Woodbridge 16
Houston 11
Turin 7
Abidjan 6
Ann Arbor 6
Singapore 6
Guangzhou 5
Lawrence 5
Los Angeles 5
Princeton 5
Redmond 5
Tolentino 5
Washington 5
Arnold 4
Milan 4
San Diego 4
Vienna 4
Xi'an 4
Brussels 3
Helsinki 3
Pune 3
San Mateo 3
Wuhan 3
Beijing 2
Cantu 2
Falconara Marittima 2
Ningbo 2
Parma 2
Zhengzhou 2
Amsterdam 1
Brandenburg 1
Centro 1
Chicago 1
Chiswick 1
Genzano di Roma 1
Hangzhou 1
Huizhou 1
Jacksonville 1
Jiaxing 1
Kilburn 1
London 1
Mantova 1
Norwalk 1
Phoenix 1
Qingdao 1
Saint Petersburg 1
Santa Clara 1
Wuxi 1
Zibo 1
Totale 424
Nome #
A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy 169
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma 72
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 68
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis 54
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 46
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 37
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study 27
85P NSCLC-Pro ClustAI: A machine learning model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors 19
The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives 19
Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma 18
NSCLC-Pro ClustAI: A Machine Learning Model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors 17
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 15
Totale 561
Categoria #
all - tutte 2.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.949


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 52 50 1 0 3 1 2 7 3
2021/202262 0 3 0 0 15 5 5 2 8 3 9 12
2022/2023176 11 13 6 11 7 45 0 5 23 4 42 9
2023/2024154 24 3 10 10 15 36 2 1 0 6 3 44
2024/202550 50 0 0 0 0 0 0 0 0 0 0 0
Totale 561